Stacie L Demel,Joseph P Broderick
Stacie L Demel
Basilar artery occlusions (BAOs) are a subset of posterior circulation strokes. Particular issues relevant to BAOs include variable and stuttering symptoms at onset resulting in delays in diagnosis, high morbidity and mortality, and uncerta...
Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications [0.03%]
溶栓后出血和口腔及咽部血管性水肿的治疗并发症管理
Cumara B O&#x;Carroll,Maria I Aguilar
Cumara B O&#x;Carroll
Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and sho...
What is the Role for Intra-Arterial Therapy in Acute Stroke Intervention? [0.03%]
急性卒中介入治疗中动脉内治疗的作用是什么？
Cumara B O&#x;Carroll,Mark N Rubin,Brian W Chong
Cumara B O&#x;Carroll
Intravenous recombinant tissue plasminogen activator continues to be first-line therapy for patients with acute ischemic stroke presenting within the appropriate time window, but one potential limitation is the low rate of recanalization in...
Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke [0.03%]
急性缺血性卒中静脉溶栓的绝对和相对禁忌证
Jennifer E Fugate,Alejandro A Rabinstein
Jennifer E Fugate
Most of the contraindications to the administration of intravenous (IV) recombinant tissue plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These were derived from expert consensus for the National Insti...
Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset [0.03%]
发病后3小时内 versus 3至4.5小时内静脉溶栓治疗急性缺血性卒中的疗效分析
Natalie T Cheng,Anthony S Kim
Natalie T Cheng
Data from randomized clinical trials have supported the safety and efficacy of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke when administered within 3 hours of symptom onset, and regulatory approvals for ...
Vanja Douglas,Michel Shamy,Pratik Bhattacharya
Vanja Douglas
The resolution of central variant of posterior reversible encephalopathy syndrome [0.03%]
后可逆性脑病综合征中央型的影像表现
Rita Maciel,Hipólito Nzwalo,Raquel Palma et al.
Rita Maciel et al.
Magnetic resonance imaging corticospinal tract hyperintensities in progressive supranuclear palsy [0.03%]
进行性核上性麻痹的磁共振成像皮质脊髓束高信号
David W Van Wyck,Jonathan R Diaz,Yince Loh
David W Van Wyck
Edward S Claflin,Chandramouli Krishnan,Sandeep P Khot
Edward S Claflin
Although numerous treatments are available to improve cerebral perfusion after acute stroke and prevent recurrent stroke, few rehabilitation treatments have been conclusively shown to improve neurologic recovery. The majority of stroke surv...
The "starfield" pattern of cerebral fat embolism from bone marrow necrosis in sickle cell crisis [0.03%]
镰状细胞危象骨髓坏死所致脑脂肪栓塞的“星空”模式
Laxmi P Dhakal,Kirk Bourgeois,Kevin M Barrett et al.
Laxmi P Dhakal et al.
Sickle cell disease may manifest with cerebrovascular and systemic complications. Sickle crisis that results in avascular necrosis of long bones with resultant cerebral fat embolism syndrome is rare and has a characteristic "starfield" patt...